Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Switzerland

Innovative Drugs Drive Market

March 2008 | Industry News

BMI has revised its forecasts for the Swiss drug market after new figures were released by IMS Health. We now expect drug spending to reach US$5.56bn in 2012, representing a compound annual growth rate (CAGR) of 4.6%.

To read the full article, please sign in or take a free trial.

Western Europe InsightWestern Europe Channels Western Europe Countries